Documented cause
Swvl was founded in 2017 in Cairo by Mostafa Kandil, Mahmoud Nouh, and Ahmed Sabbah. The concept was compelling: fixed-route bus rides for Egyptian commuters priced out of Uber but underserved by collapsing public transit infrastructure. Passengers would book seats on private minibuses via app at prices between public transit and rideshare. The company raised $167M from investors including BECO Capital, Vostok New Ventures, and Arzan VC, expanding rapidly to Kenya, Pakistan, UAE, and then — ambitiously — the UK, Germany, Spain, Austria, and Japan. In January 2022, Swvl announced a SPAC merger with Queen's Gambit Growth Capital, targeting a $1.5B valuation. On March 31, 2022, Swvl became the first Egyptian-founded company to list on Nasdaq. On the same day of listing, the company announced it was cutting 32% of its global workforce — approximately 400 people. Revenue at listing was approximately $55M against operating losses exceeding $150M. The core economics never worked: fixed-route buses require consistent passenger density that Cairo's informal transport market could absorb but European cities — where competition from actual public transit was intense — could not. Swvl exited Europe and Asia by late 2022. In 2023, it was effectively delisted through a complex reverse transaction. The original ride-sharing product was wound down and the company attempted to pivot to B2B transit SaaS.
Alternative account: Swvl built a bus-and-van mass transit network in Egypt, Pakistan, Kenya, and other emerging markets, letting users book fixed-route rides on privately-operated minibuses. The company raised $167M and merged with Queen's Gambit Growth Capital (SPAC) in March 2022 at a $1.5B valuation, listing on Nasdaq. Five weeks after the SPAC closed, Swvl announced it was laying off 32% of its workforce (about 400 people). Over the next 18 months, the company shut operations in Egypt, Kenya, Pakistan, and European markets. The stock was delisted from Nasdaq. Swvl survived only in a significantly diminished form.